Search

Susan G. Komen Breast Cancer Foundation and Memorial Sloan Kettering Cancer Center

Institut Curie Paris, Memorial Sloan Kettering Cancer Center, and Moffitt Cancer Center P2C

Johns Hopkins University, Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center, and National Cancer Institute (NCI)

Memorial Sloan Kettering Cancer Center, Rutgers University, and National Institute of General Medical Sciences (NIGMS)

National Cancer Institute (NCI) and Memorial Sloan Kettering Cancer Center

University of Wisconsin, Madison and Memorial Sloan Kettering Cancer Center

National Cancer Institute (NCI) and Memorial Sloan Kettering Cancer Center

National Cancer Institute (NCI), St. Jude Children's Research Hospital, Memorial Sloan Kettering Cancer Center, Columbia University, Hunter College of City University of New York, The Hospital for Sick Children, and Duke University

Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center, Amarex Clinical Research, M.D. Anderson Cancer Center, and Cancer Research Institute, New York City

Johns Hopkins University, Cold Spring Harbor Laboratory, Ontario Institute for Cancer Research, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, and Stand Up To Cancer

Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI), and American Lebanese Syrian Associated Charities (ALSAC)

Memorial Sloan Kettering Cancer Center, University of Alberta, National Institutes of Health (NIH), and Olusegun Alatise, Professor/Consultant Surgeon

Memorial Sloan Kettering Cancer Center and Olusegun Alatise, professor

Memorial Sloan Kettering Cancer Center, Lagos State University, University of Ilorin Teaching Hospital, Federal Medical Centre, Owo, University of Maiduguri Teaching Hospital, National Hospital, Abuja, and Olusegun Alatise, MB.ChB (Ife), M.Sc, FWACS, FMCS, FACS

Memorial Sloan Kettering Cancer Center and Olusegun Alatise, Dr

Melanoma Research Foundation Breakthrough Consortium, Bristol-Myers Squibb, University of Colorado, Denver, University of California, San Francisco, Vanderbilt University, Columbia University, University of Pittsburgh, Yale University, M.D. Anderson Cancer Center, H. Lee Moffitt Cancer Center and Research Institute, Memorial Sloan Kettering Cancer Center, Northwestern University, and Dana-Farber Cancer Institute

Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI), and Michael Hoyt, Associate Professor

National Cancer Institute (NCI), Memorial Sloan Kettering Cancer Center, and Y-mAbs Therapeutics

Seoul National University Hospital, Asan Medical Center, Severance Hospital, Seoul St. Mary's Hospital, Korea University Guro Hospital, DongGuk University, Inha University Hospital, Konkuk University Medical Center, Ewha Womans University, Chungnam National University Hospital, University of Virginia, Memorial Sloan Kettering Cancer Center, Yale University, Mayo Clinic, University of Texas Southwestern Medical Center, University Hospitals Coventry and Warwickshire NHS Trust, Khon Kaen University, King Chulalongkorn Memorial Hospital, The Affiliated Hospital of Qingdao University, Beijing Hospital, All India Institute of Medical Sciences, New Delhi, and Hyun Joo Ahn, Professor

University of Minnesota, Stanford University, Dana-Farber Cancer Institute, Vanderbilt University, Medical College of Wisconsin, Washington University School of Medicine, H. Lee Moffitt Cancer Center and Research Institute, Memorial Sloan Kettering Cancer Center, and National Cancer Institute (NCI)

National Center for Complementary and Integrative Health (NCCIH), National Institutes of Health (NIH), and Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center

New Approaches to Neuroblastoma Therapy Consortium and Memorial Sloan Kettering Cancer Center

National Cancer Institute (NCI), Memorial Sloan Kettering Cancer Center, H. Lee Moffitt Cancer Center and Research Institute, University of Rochester, and Katie Devine, PhD, MPH, Assistant Professor Pediatrics

Memorial Sloan Kettering Cancer Center and University of California, San Francisco

Food and Drug Administration (FDA), National Center for Advancing Translational Sciences of the National Institutes of Health, Cannonball Kids' Cancer Foundation, Rally Foundation for Childhood Cancer Research, Hyundai Hope On Wheels, St. Baldrick's Foundation, United States Department of Defense, Andrew McDonough B+ Foundation, Kaul Pediatric Research Institute, NIH/National Cancer Institute Cancer Center Support Grants to the University of Alabama at Birmingham, Memorial Sloan Kettering Cancer Center, Kelsie's Crew, Eli's Block Party Childhood Cancer Foundation, Eli Jackson Foundation, Jaxon's F.R.O.G. Foundation, Battle for a Cure Foundation, Sandcastle Kids, and Gregory K. Friedman, MD, Principal investigator

Memorial Sloan Kettering Cancer Center and Fred Hutchinson Cancer Center

Memorial Sloan Kettering Cancer Center

New York Hospital Queens, Memorial Sloan Kettering Cancer Center, and National Cancer Institute (NCI)

Memorial Sloan Kettering Cancer Center

National Cancer Institute (NCI), American Cancer Society, Inc., and Memorial Sloan Kettering Cancer Center

Celgene Corporation, Millennium Pharmaceuticals, Inc., Massachusetts General Hospital, Cape Cod Hospital, Beth Israel Deaconess Medical Center, Emory University, University of Michigan, Fox Chase Cancer Center, Memorial Sloan Kettering Cancer Center, Fred Hutchinson Cancer Center, Barbara Ann Karmanos Cancer Institute, Duke University, University of California, San Francisco, University of Chicago, M.D. Anderson Cancer Center, UNC Lineberger Comprehensive Cancer Center, Roswell Park Cancer Institute, Stanford University, University of Mississippi Medical Center, Icahn School of Medicine at Mount Sinai, Wake Forest University Health Sciences, University of Arizona, OHSU Knight Cancer Institute, Eastern Maine Medical Center, University of California, San Diego, University of Alabama at Birmingham, University of Pittsburgh Medical Center, Ochsner Health System, University of Texas Southwestern Medical Center, State University of New York - Downstate Medical Center, Newton-Wellesley Hospital, Baylor College of Medicine, City of Hope Medical Center, University of Florida, Northwell Health, H. Lee Moffitt Cancer Center and Research Institute, Vanderbilt University Medical Center, Ohio State University, Huntsman Cancer Institute, Columbia University, and Paul Richardson, MD, Principal Investigator

Memorial Sloan Kettering Cancer Center, Fred Hutchinson Cancer Center, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, and Advancing Cancer Treatment, Inc.

National Cancer Institute (NCI), Memorial Sloan Kettering Cancer Center, and The Emmes Company, LLC

Memorial Sloan Kettering Cancer Center and Jeffrey Kern, Professor of Medicine

Norwegian Cancer Society, University of Bergen, Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, University Hospital, Akershus, University of York, and University of Tromso

Adenoid Cystic Carcinoma Research Foundation, Memorial Sloan Kettering Cancer Center, Hadassah Medical Organization, and Engage Health Inc.

Rutgers Cancer Institute of New Jersey, East Carolina University, Stanford University, Harvard University, Yale University, University of Pennsylvania, Medical College of Wisconsin, Memorial Sloan Kettering Cancer Center, University of Texas Southwestern Medical Center, Johns Hopkins University, and Loyola University

Memorial Sloan Kettering Cancer Center and Bruce Korf, MD, Chair of of the NFCTC; Protocol PI

National Cancer Institute (NCI), St. Jude Children's Research Hospital, Memorial Sloan Kettering Cancer Center, City University of New York, School of Public Health, University of California, San Francisco, and Columbia University

National Cancer Institute (NCI), Janssen Scientific Affairs, LLC, Montefiore Medical Center, Memorial Sloan Kettering Cancer Center, AIDS and Cancer Specimen Resource, and The Emmes Company, LLC

Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI), City of Hope Medical Center, and William H. Redd, Professor

National Cancer Institute (NCI), American Society of Clinical Oncology, Rally Foundation, Memorial Sloan Kettering Cancer Center, University of Minnesota, St. Baldrick's Foundation, American Institute for Cancer Research, and American Cancer Society, Inc.

Bristol-Myers Squibb, Emory University, Washington University School of Medicine, Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute, Wake Forest University Health Sciences, Memorial Sloan Kettering Cancer Center, Icahn School of Medicine at Mount Sinai, University of Texas, Hackensack Meridian Health, and University of Michigan

Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Bayer, Cancer Trials Ireland, Canadian Cancer Trials Group, Memorial Sloan Kettering Cancer Center, and Prostate Cancer Clinical Trials Consortium

Bristol-Myers Squibb and Memorial Sloan Kettering Cancer Center

University of Colorado, Denver, Memorial Sloan Kettering Cancer Center, and Erasmus Medical Center

Memorial Sloan Kettering Cancer Center, Weill Medical College of Cornell University, and Rockefeller University

Memorial Sloan Kettering Cancer Center, Indiana University, H. Lee Moffitt Cancer Center and Research Institute, City of Hope Medical Center, Hackensack Meridian Health, and Jeanne Mandelblatt, Professor